ClinVar Miner

Submissions for variant NM_004364.5(CEBPA):c.556C>T (p.Pro186Ser)

dbSNP: rs1303742006
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV001208627 SCV001380026 uncertain significance Acute myeloid leukemia 2023-06-05 criteria provided, single submitter clinical testing ClinVar contains an entry for this variant (Variation ID: 939256). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. This variant has not been reported in the literature in individuals affected with CEBPA-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces proline, which is neutral and non-polar, with serine, which is neutral and polar, at codon 186 of the CEBPA protein (p.Pro186Ser).
Baylor Genetics RCV001208627 SCV005057301 uncertain significance Acute myeloid leukemia 2023-12-06 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.